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Polymorphonuclear leukocytes (pMNL) exposed to chemoattractants or cytokines change their
functional capacity. The effect of endotoxin-activated serum as a priming agent on human PMNL
was tested. Pretreatment ofPMNL with endotoxin-activated serum increased their oxidative burst
in response to formylpeptide (FMLP) (P< .02)and CSa (P < .05). Priming for membrane depolar-
ization was observed in PMNL preincubated with either endotoxin-activated serum, low concen-
trations of purified C5a, or endotoxin but not with decomplemented plasma. Primed PMNL
had an increased number of FMLP but not C5a receptors as compared with control PMNL. The
"resting" cytosolic freecalcium was increased in primed PMNL (P < .02). Intracellular calcium
buffering abolished the priming effect of endotoxin-activated serum. Thus, endotoxin-activated
serum can prime cellular responsiveness for membrane depolarization and superoxide produc-
tion in response to FMLP and to C5a. Priming may be due to an increased resting cytosolic-free
calcium.
Polymorphonuclear leukocytes (PMNL) are end-stage cells
that play an important role in host defense and inflammation
[1]. Upon exposure to chemoattractants, they are capable of
improving their functional capacity [2]. Immature PMNL such
as those. from patients with myelodysplastic syndromes or
leukemia have functional defects [3, 4]. In contrast, extravas-
cular PMNL, that is, those in an advanced life stage, have
an increased responsiveness to N-formylmethionylleucyl-
phenylalanine (FMLP) compared to blood PMNL from the
same species [2]. The exact mechanisms of this functional
improvement (priming) are unknown but may at least be par-
tially due to FMLP-receptor upregulation [2].
In this study we analyzed the effectof prestimulation ofhu-
man PMNL in vitro on their subsequent responsiveness. The
phenomenon of priming was investigatedby incubating PMNL
with either endotoxin-activated serum (EAS) or some of its
components, namely endotoxin, C5a, and decomplemented
plasma. EAS was used because it most closely simulates the
clinical situation of gram-negative sepsis, during which PMNL
may be primed. The importance of migration in the cellular
priming was analyzed by using a chemotactic chamber as an
in vitro model of locomotion. Cellular responsiveness of EAS-
pretreated PMNL to FMLP and purified C5a was measured.
The mechanisms of priming were analyzed in terms ofFMLP-
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and C5a-receptor studies. Because not every priming could
be explained byreceptor upregulation, we investigatedwhether
an increased "resting" cytosolic-free calcium ([Ca2+]i) could
be involved.
Materials and Methods
Reagents. Reagents used and their sources were: bovine serum
albumin, cytochalasin B, cytochrome C (type IV), dimethyl sulfox-
ide, HEPES, FMLP, phenolphthalein glucuronic acid solution,
phenolphthalein, phenolphthalein standard solution, phorbol myris-
tate acetate (PMA), quin 2 acetoxymethylester (quin 2-AM), quin
2 free acid, and triton X-loo (Sigma Chemical, St. Louis); dextran
T-5oo and Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden);
endotoxin lipopolysaccharide-B Escherichia coli026 (Difco Labora-
tories, Detroit); 57Co-B12 and FML[3H]P (specific activity 60
Ci/mmol; New England Nuclear, Boston); EDfA and activated char-
coal (Merck AG, Zurich); polymyxin Band ionomycin(Calbiochem,
San Diego); 3,3'-dipentyloxacarbocyanine iodide (di-0-C5(3); Mo-
lecular Probes, Junction City, OR), and Harleco Diff-Quik (Merz
& Dade AG, Diidingen, Switzerland). HEPES-Hanks' balanced salt
solutions with (HBSS) or without calcium and magnesium (mHBSS)
were prepared according to standard methods [5]. FMLP, PMA,
and EAS were prepared as described by Metcalf et al. [5].
Isolation of PMNL. Human blood PMNL were purified from
EUfA-anticoagulated (5 roM final concentration) blood, drawn by
venipuncture from healthy human volunteers. Purification included
dextran T-5oo (3% in 0.9% saline) sedimentation and subsequent
centrifugation (350 g for 30 min at 4°C) on a 53%/67 % Percoll gra-
dient, similar to that previouslydescribed [2, 6]. PMNL accumulating
at the interphase of the gradient were washed twice in 0.9% saline.
Hypotonic lysis was performed, if necessary, with distilled water
and correction of the osmolarity with 1.8% NaCI after 15-30 s.
Pretreatment of PMNLin vitro. Purified PMNL (>98% pure)
were suspended in HBSS supplemented with 0.1% glucose and 0.1%
bovine serum albumin at a concentration of 1 x 107 PMNL/ml.
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The priming agents were added in different concentrations (see
Results). Incubations were performed in Falcon plastic tubes (Bec-
ton Dickinson, Oxnard, CA) on an overhead rotator at J'lDC, and
terminated after 30 minbyadding ice-eold mHBSS. Pretreated PMNL
were washed twice with mHBSS and then resuspended at 107
PMNL/ml for use in the functional assays. Migrated PMNL (CTX-
EAS-PMNL) were washed away fromthe lower part of a lQ-JLm thick,
5-JLm pore diameter chemotaxis filter (Nucleopore, Pleasanton, CA),
and from the lower wells of a chemotaxis microchamber (Neuro
Probe, Cabin John, MD) containing 1.7% EAS. These PMNL, which
migrated through the filter within 30 min, were washed twice before
use in the functional assays. Control PMNL were incubated in
HBSS/O.l% glucose/OJ% albumin alone.
Control experiments. Endotoxin modulates PMNL functions at
low concentrations [7-11]. Therefore, any solution used for the
purification and preincubation procedure was tested for its endotoxin
contamination by the amoebocyte lysate assay (Pyrogel; Skan AG,
Basel, Switzerland). H20 , saline, EllA, dextran, and C5a (10-9 M)
contained <l ng/ml endotoxin. HBSS-albumin and Percoll (53 % and
67%) had an endotoxin contamination of <100 ng/ml. Since poly-
myxin B binds endotoxin, we compared PMNL preparations iso-
lated in either the presence or absence of polymyxin B (10 JLg/ml)
[12]. The priming effect of endotoxin (5 JLg/ml) in the superoxide
assay was identical in the two different PMNL preparations (data
not shown).
Membrane potential. Membrane potential was determined in a
fluorescence spectrophotometer (LS5; Perkin-Elmer, Norwalk, CT)
with the fluorescent probe di-O-C5(3) as previously described [13].
Superoxide production. Superoxide (02-) production was deter-
mined at J'lDC spectrophotometrically (550 nm, mM extinction
coefficient of 21,100M-I em:') by continuously monitoring the O2--
dismutase (300 units/ml)-inhibitable reduction of cytochrome-C (120
JLg/ml) in a double-beam spectrophotometer (model 35, Beckman
Instruments, Fullerton, CA) with a temperature regulator set, as de-
scribed previously [6].
C5a purification and labeling. C5a was purified from human
yeast-activated plasma as described by Hugli et al. [14]. C5a was
homogenous as shown by a single band on PAGEand on microzone
electrophoresis at pH 8.6. The protein content was determined by
amino acid analysis. Purified C5a was radiolabeled with 1251 using
a solid-phase lactoperoxidase-glucose oxidase method according to
Hugli and Chenoweth [15]. The initial specific activity was 160
Ci/mmol.
Receptor assays. FMLPH]P binding to PMNL was carried out
at 4DC for 20 min using a silicon-oil technique as described previously
[2, 16]. For Scatchard analyses final concentrations of FMLPH]P
in binding assays varied from 3 to 200 nM. Nonspecific binding was
determined with a parallel series of samples by adding a lOoo-fold
excess ofunlabeled FMLP. Scatchard plots of the experimental data
(specific bindings) were fitted by linear regression. The dissociation
constant (Kd) and receptor number (Bmax) were estimated from the
fitted slopes and x intercepts [2]. 12S1-C5a binding to PMNL was
carried out at 4 DC using a silicon-oil technique, similar to that de-
scribed by Huey and Hugli [17]. The incubation time was 45 min.
For Scatchard analyses final concentrations of 12sl-C5a in binding
assays were 0.08-20 nM. To determine the nonspecific binding,
purified cold C5a was added to a parallel series of samples at a final
concentration of2.5 JLM. Nonspecific binding was routinely <10%.
The data were treated as described above. The specific activity of
12sl-C5a was determined for each separate assay.
Measurement of cytosolic-free calcium ([Ca2+j J . Control and
EAS-PMNL were loaded with quin 2-AM as follows: Cells were
incubated in HBSS supplemented with glucose (0.1%) at a concen-
tration of 1 X 107 PMNL/ml with quin 2-AM at a final concentra-
tion of 1 pM. Quin 2-AM was diluted 10-fold with 50% dimethyl
sulfoxide/HBSS from a 2 mM stock solution in dimethyl sulfoxide
before addition to PMNL. Quin 2 loading of PMNL was performed
in a 30-min incubation with overhead rotation. Loading of 0.2-0.4
nmol of quin 2/1Q6 PMNL was obtained. After loading, cells were
washed twice and resuspended in glucose-supplemented HBSS. Cells
were diluted to 2.5 x lQ6PMNLlml, maintained at room temper-
ature, and protected from light until use. Control cells were incubated
with an equivalent concentration of dimethyl sulfoxide and treated
identically.
To determine the role of [Ca"], in cellular priming, [Ca"], was
buffered with quin 2 in control experiments. For this purpose PMNL
(1 x 107/ml) were incubated 30 min in calcium-free HBSS/OJ %
glucose with quin 2-AM at a final concentration of 10 JLM, which
resulted in a loading of 2 nmol of quin 2/1Q6 PMNL.
Fluorescent measurements were performed with a Perkin-Elmer
fluorimeter (LS5; Perkin-Elmer) with two cutoff filters as described
by Lew et al. [18]. The calculation of the loading and [Ca2+]i was
performed as described by Metcalf et al. [5].
[Ca2+j i dependency of O2- production. To transiently increase
[Ca"}, ionomycin (500 nM final concentration) was added to
PMNL in calcium-free medium (mHBSS), as described by Lewet
al. [19]. This increase was recorded with thequin 2 method. In con-
current experiments, FMLP-induced O2- production was measured
in identically treated PMNL at different intervals after the addition
of ionomycin.
Statistics. As an estimate of variance, standard deviation of the
mean was used in the text and tables and standard error in the figures.
Means were compared by Student's t test.
Results
Specificandprimary granules inprimed PMNL. Limited
degranulation of specific granules is possibly one of the criti-
cal events in the cellular priming process. We therefore de-
termined the content of specific and primary granules in
PMNL preincubated either in HBSS/OJ % glucose/OJ% al-
bumin or in 1.7% EAS or that had migrated through 5-Jtm
holes of a 10-Jtm polycarbonate filter toward 1.7% EAS. Ta-
ble 1 summarizes the results. Pretreatment of PMNL with
1.7% EAS and migration toward EAS induced a preferential
loss of specific granules. The primary granule marker {3-g1u-
curonidase did not significantly differ in the three cell types.
Superoxide production. We next studied the effect of EAS
preincubation on the subsequent O2-' production in response
to FMLP and C5a. O2- production was determined in the
presence and absence of cytochalasin B, since pretreatment
of PMNL with cytochalasin B by itself enhances and prolongs
the respiratory burst induced by FMLP and C5a [20]. Figure
1 shows the O2- production rate in EAS-PMNL compared
244 Zirnmerli et al. JID 1990;161 (February)
Table 1. Granule content of untreated (control) and pretreated polymorphonuclear leuko-
cytes (PMNL).
Cell type
B-12 binding
protein (%)
p
(paired t test)
~-gIucuronidase
(ug phenolphthalein
released/4 hI
106 PMNL) (%)
Control PMNL
EAS-PMNL*
EAS-CTX PMNL t
496 ± 62 (100) }
429 ± 62 (87. ± 6.4) }
417 ± 64 (84 ± 6.2)
.002 }
.001
.001
174 ± 21 (100)
170 ± 16 (98 ± 4.4)
169 ± 17 (97 ± 4.1)
NOTE. Total granule content was determined by lysing the PMNL suspension (5 X 1()6 PMNLlml) with triton
X-IOO(0.1 %). Experiments were performed on six different days with PMNL from six different volunteers. All three
PMNL types were prepared from the same cell batch. Results are mean ± so.
* PMNL were preincubated with endotoxin-activated serum (EAS).
t PMNL that migrated previously toward EAS through a 5-l1m-pore nitrocellulose filter.
Figure 1. Superoxide production (02-) of blood polymor-
phonuclear leukocytes (PMNL) incubated (37°C for 30 min) either
in HBSS/OJ% glucose/OJ % albumin (C) or in 1.7% endotoxin-
activated serum (EAS). PMNL were washed twice before testing
O2- production. A, Maximal initial rate in response to 10-6 M for-
mylpeptide (FMLP) in the presence or absence of cytochalasin B.
B, Corresponding results in response to 10-7 M C5a. Statistical
analysis was performed by paired t test. Results are means ± SE
of six different experiments.
withcontrolcells.Interestingly, whenPMNL were stimulated
with 10-(; M FMLP, the priming effect of EAS was observed
only in the absenceof cytochalasin B. However, at a submax-
imal concentration of FMLP (10-7 M) priming was observed
both in the absence (2.7 ± 0.2 vs. 1.7 ± 0.4 nmol of O2-/
min/1Q6 PMNL; P < .05) and in the presence (5 ± 1.0vs.
3.3 ± 0.25 nmol of 02-/min/1Q6 PMNL; P < .05) of
cytochalasin B. The responsiveness of EAS-PMNL wasalso
increased by stimulation with 10-7 M C5a (figure lB),
regardless of the presence of cytochalasin B.
BypreincubatingPMNL witha substimulatoryconcentra-
tion of C5a (1Q-9 M), their responsiveness toward FMLP
(10-6 M) was increased (5.0 ± 0.6 vs. 2.7 ± 0.6 nmol of
02-/min/1Q6 PMNL; P < .001). In contrast, the responsive-
ness toward cytochalasin B plus C5a (10-7M) decreased (1.1
± 0.6 vs. 2.0 ± 1.2 nmol of O2-/min/l06 PMNL; P < .05).
Effect of different priming factors on FMLP- and C5a-
induced membrane depolarization. Using the membrane
depolarizationassay, previously showntobe a convenient test
to detectpriming[13], weanalyzedwhichcomponentof EAS
might be responsiblefor PMNL primingand whethermigra-
tion influenced the priming process. Figure 2A shows that
the responseofPMNLpreviouslyincubatedwith EAS, C5a,
or endotoxin, but notdecomplemented plasma,wassimilarly
enhanced toward 10-6 M FMLP, as was the response of
PMNL which had previouslymigrated througha chemotac-
tic filter. Primingdidnotresult in a modified dose-dependency
response; that is, the FMLP concentration leading to half-
maximaldepolarizationwas similar betweenEAS-and con-
trol PMNL (2 X 10-8 ± 1.4 X 10-8 M vs. 2.4 X 10-8 ± 1.3
x 10-8 M, respectively; n = 8 pairs).
Figure 2B shows the membrane depolarizationof different
PMNL preparations in response to 10-8 M C5a. With this
stimulus, the priming effectof EAS (1.7 %), C5a (10-9 M) or
endotoxin(5 p.g/ml) wasevenhigher, reaching between170%
(C5a)and210% (EAS) abovecontrols.However, the C5acon-
centration eliciting half maximal depolarization was some-
what higher in EAS-PMNL than in control cells (4.3 x
10-10 ± 9.4 x 10-11 M vs. 3.6 X 10-10 ± 9.4 X 10-11 M,
respectively; n = 8 pairs, P< .05). Ata nondepolarizing con-
centration of C5a (10-10 M) in the preincubation, the prim-
ing for C5a (10-8 M)-inducedmembrane depolarizationwas
in the same range, 159% ± 7% of the control. Thus, in con-
trast to O2- production, pretreatment with a low concentra-
tion of a stimulus identical to that used in the restimulation
led to priming and not to deactivation of the membrane
depolarization.
Requirements for priming. Priming by EAS was a rapid
process. Figure 3 shows that it was detectable at 5 min and
reached a plateauwithin20 min. The different requirements
are summarizedin table 2. Priming for FMLP-inducedO2-
productionoccurredat lowconcentrations ofEAS;it wastem-
C EAS C EAS
-Cyto b +Cyto b
C EAS C EAS
-Cyto b +Cyto b
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Figure 3. Influence of priming time on formylpeptide (FMLP)-
induced superoxide (02- ) production. PMNL were incubated either
in HBSS/OJ%glucose/OJ %albumin or in 1.7%endotoxin-activated
serum. PMNL were diluted into ice-cold HBSS and washed twice
at corresponding time points. Results are means ± SE of triplicates
from a representative experiment.
Table 2. Requirements for the priming process: Oz - production
rate in response to 10-6 M formyl peptide (FMLP) (nmol/min/
106/PMNL).
Control-
Experimental conditions EAS-PMNL* PMNLt Significance'[
EAS-concentrations
0.007% 2.3 ± 0.21 <.025
0.33% 3.0 ± 0.8 1.5 ± 0.3 <.025
3.3% 3.2 ± 1.3 <.05
Temperature
O°C 1.7 ± 0.1 1.3 ± 0.2 NS
37°C 4.0 ± 0.2 1.1 ± 0.3 <.001
Protein synthesis
- cycloheximide 2.8 ± 0.5 1.3 ± 0.3 <.001
+ cycloheximide (10 ug/ml) 2.6 ± 0.4 NO
Calcium
1 mM Ca2+ 3.7 ± 1.7 1.3 ± 0.2 <.001
No Ca2+/2 mM EGTA 3.9 ± 1.3 NO
Quin 2-buffering (2 nmol
quin 2/106 PMNL), no
Ca2+/2 mM EGTA 1.7 ± 0.2 1.7 ± 0.4 NS
NOTE. EAS = endotoxin-activated serum, PMNL = polymorphonuclear leuko-
cytes. Each experiment was performed in triplicate at least three times.
* Incubation for 30 min with 1.7% EAS if not otherwise stated.
t Incubation for 30 min with HBSS/O.I % glucose/O.t % bovine serum albumin.
*Comparison between control and EAS-PMNL (paired t test): P value; NS = not
significant.
As an alternative possible priming mechanism, we exam-
ined the intracellular calcium in primed and unprimed PMNL.
Figure 6 shows that primed cells had a consistently higher
"resting" [Ca2+]i than control PMNL. This difference was
significant (P < .02) with cells isolated from five different
donors.
To investigate whether an increased [Ca2+1 at the time of
stimulation with an agonist can enhance the PMNL response,
we measured the ~- production at different [Ca2+U concen-
trations. PMNL were pretreated with ionomycin to evaluate
p<0.02p<0.01p<0.01
- NSp<O.o1 p<0.02 p<o.oS p<0.02
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perature dependent and required neither protein synthesis nor
extracellular calcium. However, no priming was observed
when intracellular calcium was buffered with quin 2 before
incubation of PMNL with EAS in calcium-free buffer.
Mechanisms ofpriming. To determine whether the ob-
served limited degranulation of specific granules increased
receptor number, FMLP and C5a receptors were determined.
Figure 4 shows that the number of FMLP receptors was 1.4-
fold higher in EAS-preincubated PMNL (P < .05) but this
was not accompanied by a significant alteration in affinity.
Preincubation with endotoxin alone did not significantly in-
crease FMLP receptors: 22,000 ± 5400 per control PMNL
and 26,400 ± 11,100 per endotoxin-primed PMNL (n = 5
pairs). Figure 5 shows that in cells, whether EAS primed or
not, C5a receptors were similar in number and affinity under
conditions in which the number of FMLP receptors was in-
creased.
Figure 2. Effect of priming factors on 10-6 M formylpeptide
(FMLP)- (A) and 10-8 M C5a- (B) induced membrane depolariza-
tion. Polymorphonuclear leukocytes (PMNL) were incubated for 30
min in either HBSS/OJ% glucose/OJ% albumin (control), 1.7%
endotoxin-activated serum (EAS), purified C5a (l0-9 M), endotoxin
(5 ~g/ml), or decomplemented plasma (1.7%). PMNL that had pre-
viously migrated through a chemotactic filter toward 1.7%EAS were
labeled with EAS + CTX. PMNL were washed twice before testing
membrane depolarization. Results are means ± SE of 4-12 differ-
ent experiments. Statistical analysis was performed by paired t test.
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Figure 4. Total fonnylpeptide (FMLP) receptors per cell (left) and affinity constant (Kd) (middle). Polymorphonuclear leukocytes (PMNL)
were preincubated and washed as described in Methods. Left and middle panels present results from Scatehard analyses performed on
control and endotoxin-activated serum (EAS)-treated PMNL (pairs). Each pair represents an individual experiment. Significance of differ-
ence between means was determined by two-tailed Student's t test. Right panel shows Scatehard plot of representative experiment with
control and EAS-incubated PMNL.
the [Ca"], and thereafter stimulated with FMLP at different
intervals and levels of [Ca"], Figure 7 shows a good rela-
tionship between the [Ca2+]; at the time of stimulation and
the O2- production rate that rose to values 2.2-4.2-fold above
the baseline in five different experiments.
Discussion
It has been observed previously that PMNL modify their
functional characteristics by sequential stimulation [16, 21-24].
These modifications are many and can besummarized as deac-
tivation, adaptation, and priming. In our present study, we
asked the following questions: Does EAS prime PMNL for
FMLP- and C5a-induced functions? And, if so, which are the
requirements for the EAS-induced priming? Also, what are
the priming mechanisms?
By using highly purified C5a, we analyzed the effect of EAS
prestimulation, even on cell functions that require high con-
centrations of the complement-derived chemotactic factor for
stimulation. The use of C5a and FMLP allowed us to detect
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Figure S. Total C5a receptors per cell (left) and affinity constant (Kd) (middle). Polymorphonuclear leukocytes (PMNL) were prein-
cubated and washed as described in Methods. Left and middle panels present results from Scatchard analyses performed on control and
endotoxin-activated serum (EAS)-treated PMNL (pairs). Each pair represents an individual experiment. Significance of difference between
means was determined by two-tailed Student's t test. Right panel shows Scatehard plot of representative experiment with control and EAS-
incubated PMNL.
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Figure 7. Representative experiment showing the dependency of
superoxide (02- ) production on [Ca"], in response to formylpep-
tide (FMLP). [Ca"], was transiently increased by adding ionomy-
cin (500 p,Mfinal concentration) to polymorphonuclear leukocytes
(PMNL) in calcium-free medium (mHBSS) [13]. Changes in [Ca"],
were recorded with the quin 2 method. In concurrent experiments,
FMLP-induced O2- production was measured in identically treated
PMNL at different intervals after the addition of ionomycin. Values
of 100% represent the maximal increases for [Ca"], and O2-
production above the baseline value. Experiments with PMNL from
four other donors gave similar results.
macrophage colony-stimulating factor [29-32], tumor necrosis
factor-a [33], and endotoxin [10, 11, 28], have been shown
to enhance the response triggered by a second agonist. Prim-
ing with EAS occurs rapidly (figure 3), whereas prolonged
incubation is required for the action of lipopolysaccharide or
cytokines [7, 10, 11, 28]. Thus, the mechanism of priming
by EAS might differ from that by cytokines and endotoxin.
Most priming agents such as chemotactic factors induce a
limited degranulation of secondary granules and mobilize
FMLP and C3bi receptors. It has been suggested that FMLP-
receptor upregulation might be responsible for the enhanced
responsiveness of PMNL [2, 16, 34]. We found an increase
ofFMLP receptors, after preincubation ofPMNL with EAS
(figure 4) but not with endotoxin. Further, preincubation of
PMNL with EAS did not result in an upregulation of C5a
receptors. Since we demonstrated that priming does not re-
sult in an increased number or affinity of C5a receptors but
still enhances a response triggered by C5a, mechanisms other
than receptor upregulation must be operative in the priming
process.
Forehand et al. [35] recently offered an explanation for the
priming ofPMNLwith lipopolysaccharide. They found a 1.6-
fold increase of the resting [Ca"], in lipopolysaccharide-
treated PMNL. We found a similar increase of the resting
[Ca 2+] i in PMNL primed with EAS. Finkel et al. [36]
showed that increasing the [Ca"], of PMNL with ionomycin
potentiated their oxidative burst in response to different stim-
uli. The positive association between the O2- production rate
and the [Ca"], at the time of stimulation with FMLP (figure
7) points out the relevance of theincreased resting [Ca"] as
priming factor.
CONTROL EAS
PMNL PMNL
Figure 6. Resting cytosolic free calcium ([Ca 2+]i) in control and
endotoxin-activated serum (EAS)-treated polymorphonuclear leu-
kocytes (PMNL) (pairs). PMNL were preincubated and washed as
described in Methods. [Ca2+]i was determined in resting cells by the
quin 2 method. Significance of difference between means was deter-
mined by two-tailed t test.
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possible discordant reactivity of EAS-PMNL, namely deac-
tivation for one stimulus and priming for the other [2].
Control experiments confirmed that our PMNL prepara-
tions, isolated on a Percoll gradient, were not activated to a
significant degree, since the priming was similar for PMNL
prepared either in the presence or in theabsence of polymyxin
B. Further, significant priming with <100 nglml endotoxin
occurs only after an incubation of >30 min [7].
EAS-pretreated PMNL had a lower residual content of
specific granules than did control PMNL. This effect was even
more prol'ltlWlCed in PMNL that had migrated through a filter
in response to BAS. However, the enhancement of cellular
responsiveness toward a second agonist was identical regard-
less of whether thecells had migrated, indicating that a larger
degree ofdegnmulation of secondary granules does not neces-
sarily lead to a stronger priming.
In the presence of cytochalasin B, priming was observed
only with a submaximal concentration of FMLP (10-7 M).
This indicates that the respiratory burst was maximally stimu-
lated by cytochalasin Band 10-6 M FMLP. PMNL prein-
cubated with 10-9 M C5a showed a primed membrane
depolarization but a deactivated O2- production in response
to C5a. This discrepancy remains unexplained and argues
against a causal relationship between changes in membrane
potential and subsequent oxidative burst.
The mechanisms of priming remain unknown. Many medi-
ators, including low concentrations of LTB4 [25, 26], 5-HETE
[21], platelet activating factor [26, 28], FMLP [21, 22,·24],
and C5a (as shown here), plus cytokines such as granulocyte-
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This proposed priming mechanism is compatible with the
observed priming requirements (table 2). Since priming also
occurred in the absence of extracellular calcium, the small
increase of intracellular free calcium arises via mobilization
from intracellular pools [37]. This is also supported by the
lack of priming after buffering [Ca2+]i with quin 2. A simi-
lar observation was made by Forehand et al. [35], who could
abolish the endotoxin-induced priming by MAPTAM, another
intracellular Ca2+ chelator.
In conclusion, we demonstrated that EAS primes PMNL
for both FMLP- and C5a-induced function without affecting
C5a receptor number and affinity. Therefore receptor upregu-
lation cannot be the priming mechanism for every stimulus.
EAS-treated PMNL had an increased resting ICa2+]i, which
may be responsible for their priming, since FMLP-induced
O2- production was increased in PMNL with a higher [Ca2+]i
at time of stimulation and HAS did not prime PMNL in which
[Ca2+]i was buffered during preincubation.
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